-

Eurofins Scientific SE: Weekly Report on Share Repurchases From 06th July to 10th July 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins Scientific SE (Paris:ERF):

Weekly report on share repurchases from 06th July to 10th July 2026

 

 

 

Name of the

Issuer

Identify code of the

Issuer

Transaction

day

Identify code of

the financial

instrument

Total daily

volume (in

number of

shares)

Daily

weighted

average

purchase

price of

the shares

Market

(MIC

Code)

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

06/07/2026

FR0014000MR3

14 939

69.6189

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

06/07/2026

FR0014000MR3

5 061

69.4770

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

07/07/2026

FR0014000MR3

5 000

69.5902

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

07/07/2026

FR0014000MR3

15 000

69.5918

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

08/07/2026

FR0014000MR3

15 000

67.1748

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

08/07/2026

FR0014000MR3

5 000

67.1447

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

09/07/2026

FR0014000MR3

5 000

67.8878

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

09/07/2026

FR0014000MR3

20 000

67.7235

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

10/07/2026

FR0014000MR3

15 000

69.5691

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

10/07/2026

FR0014000MR3

5 000

69.5491

CEUX

TOTAL

105 000

68.6859

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

Contacts

Eurofins Scientific SE

Eurofins Scientific SE

BOURSE:ERF
Release Versions
English

Contacts

Eurofins Scientific SE

More News From Eurofins Scientific SE

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Financial highlights in H1 2026 Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives. Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 13th July to 17th July 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Weekly report on share repurchases from 13th July to 17th July 2026   Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07/2026 FR0014000MR3 15 000 69.1984 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07...

Eurofins Agrees to Acquire Element Materials Technology’s Life Sciences Testing Services Business in North America

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), a global scientific leader in bioanalytical testing, has reached an agreement with Element Materials Technology (“Element”) to acquire its Life Sciences Testing Services business in North America, for an enterprise value of $400m. The transaction is subject to customary conditions, including regulatory approvals, and is expected to close in Q4 2026. Element’s North America Life Sciences Testing Services inc...
Back to Newsroom